A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα

Simon Ducheix, Normand Podechard, Frédéric Lasserre, Arnaud Polizzi, Aurélien Pommier, Stefania Murzilli, Chiara Di Lisio, Simona D'Amore, Justine Bertrand-Michel, Alexandra Montagner, Thierry Pineau, Nicolas Loiseau, Jean Marc Lobaccaro, Pascal G P Martin, Hervé Guillou

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The Liver X Receptors (LXRs) α and β and the Peroxisome Proliferator-Activated Receptor α (PPARα) are transcription factors that belong to class II nuclear receptors. They drive the expression of genes involved in hepatic lipid homeostasis and therefore are important targets for the prevention and treatment of nonalcoholic fatty liver disease (NAFLD). LXRs and PPARα are regulated by endogenous ligands, oxysterols and fatty acid derived molecules, respectively. In the liver, pharmacological activation of LXRs leads to the over-expression of genes involved in de novo lipogenesis, while PPARα is critical for fatty acid catabolism in nutrient deprivation. Even if these two nuclear receptors seemed to play opposite parts, recent studies have highlighted that PPARα also influence the expression of genes involved in fatty acids synthesis. In this study, we used pharmacological approaches and genetically engineered mice to investigate the cross-talk between LXRs and PPARα in the regulation of genes responsible for lipogenesis. We first investigated the effect of T0901317 and fenofibrate, two synthetic agonists of LXRs and PPARα, respectively. As expected, T0901317 and fenofibrate induce expression of genes involved LXR-dependent and PPARα-dependent lipogenic responses. Considering such overlapping effect, we then tested whether LXR agonist may influence PPARα driven response and vice versa. We show that the lack of PPARα does not influence the effects of T0901317 on lipogenic genes expression. However, PPARα deficiency prevents the up-regulation of genes involved in ω-hydroxylation that are induced by the LXR agonist. In addition, over-expression of lipogenic genes in response to fenofibrate is decreased in LXR knockout mice as well as the expression of PPARα target genes involved in fatty acid oxidation. Altogether, our work provides in vivo evidence for a central interconnection between nuclear receptors that drive hepatic lipid metabolism in response to oxysterol and fatty acids.

Original languageEnglish
Pages (from-to)556-567
Number of pages12
JournalBiochimie
Volume95
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Lipogenesis
Peroxisome Proliferator-Activated Receptors
Systems Biology
Liver
Genes
Fenofibrate
Fatty Acids
Gene Expression
Cytoplasmic and Nuclear Receptors
oxysterol binding protein
Liver X Receptors
Pharmacology
Hydroxylation
Lipid Metabolism
Gene expression
Knockout Mice
Nutrients
Homeostasis
Transcription Factors
Up-Regulation

Keywords

  • Lipogenesis
  • LXR
  • Oxysterol
  • PPARα
  • Steatosis

ASJC Scopus subject areas

  • Biochemistry

Cite this

A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα. / Ducheix, Simon; Podechard, Normand; Lasserre, Frédéric; Polizzi, Arnaud; Pommier, Aurélien; Murzilli, Stefania; Di Lisio, Chiara; D'Amore, Simona; Bertrand-Michel, Justine; Montagner, Alexandra; Pineau, Thierry; Loiseau, Nicolas; Lobaccaro, Jean Marc; Martin, Pascal G P; Guillou, Hervé.

In: Biochimie, Vol. 95, No. 3, 03.2013, p. 556-567.

Research output: Contribution to journalArticle

Ducheix, S, Podechard, N, Lasserre, F, Polizzi, A, Pommier, A, Murzilli, S, Di Lisio, C, D'Amore, S, Bertrand-Michel, J, Montagner, A, Pineau, T, Loiseau, N, Lobaccaro, JM, Martin, PGP & Guillou, H 2013, 'A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα', Biochimie, vol. 95, no. 3, pp. 556-567. https://doi.org/10.1016/j.biochi.2012.09.028
Ducheix, Simon ; Podechard, Normand ; Lasserre, Frédéric ; Polizzi, Arnaud ; Pommier, Aurélien ; Murzilli, Stefania ; Di Lisio, Chiara ; D'Amore, Simona ; Bertrand-Michel, Justine ; Montagner, Alexandra ; Pineau, Thierry ; Loiseau, Nicolas ; Lobaccaro, Jean Marc ; Martin, Pascal G P ; Guillou, Hervé. / A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα. In: Biochimie. 2013 ; Vol. 95, No. 3. pp. 556-567.
@article{fc875c5c31864c38822e6596b79a184f,
title = "A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα",
abstract = "The Liver X Receptors (LXRs) α and β and the Peroxisome Proliferator-Activated Receptor α (PPARα) are transcription factors that belong to class II nuclear receptors. They drive the expression of genes involved in hepatic lipid homeostasis and therefore are important targets for the prevention and treatment of nonalcoholic fatty liver disease (NAFLD). LXRs and PPARα are regulated by endogenous ligands, oxysterols and fatty acid derived molecules, respectively. In the liver, pharmacological activation of LXRs leads to the over-expression of genes involved in de novo lipogenesis, while PPARα is critical for fatty acid catabolism in nutrient deprivation. Even if these two nuclear receptors seemed to play opposite parts, recent studies have highlighted that PPARα also influence the expression of genes involved in fatty acids synthesis. In this study, we used pharmacological approaches and genetically engineered mice to investigate the cross-talk between LXRs and PPARα in the regulation of genes responsible for lipogenesis. We first investigated the effect of T0901317 and fenofibrate, two synthetic agonists of LXRs and PPARα, respectively. As expected, T0901317 and fenofibrate induce expression of genes involved LXR-dependent and PPARα-dependent lipogenic responses. Considering such overlapping effect, we then tested whether LXR agonist may influence PPARα driven response and vice versa. We show that the lack of PPARα does not influence the effects of T0901317 on lipogenic genes expression. However, PPARα deficiency prevents the up-regulation of genes involved in ω-hydroxylation that are induced by the LXR agonist. In addition, over-expression of lipogenic genes in response to fenofibrate is decreased in LXR knockout mice as well as the expression of PPARα target genes involved in fatty acid oxidation. Altogether, our work provides in vivo evidence for a central interconnection between nuclear receptors that drive hepatic lipid metabolism in response to oxysterol and fatty acids.",
keywords = "Lipogenesis, LXR, Oxysterol, PPARα, Steatosis",
author = "Simon Ducheix and Normand Podechard and Fr{\'e}d{\'e}ric Lasserre and Arnaud Polizzi and Aur{\'e}lien Pommier and Stefania Murzilli and {Di Lisio}, Chiara and Simona D'Amore and Justine Bertrand-Michel and Alexandra Montagner and Thierry Pineau and Nicolas Loiseau and Lobaccaro, {Jean Marc} and Martin, {Pascal G P} and Herv{\'e} Guillou",
year = "2013",
month = "3",
doi = "10.1016/j.biochi.2012.09.028",
language = "English",
volume = "95",
pages = "556--567",
journal = "Biochimie",
issn = "0300-9084",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα

AU - Ducheix, Simon

AU - Podechard, Normand

AU - Lasserre, Frédéric

AU - Polizzi, Arnaud

AU - Pommier, Aurélien

AU - Murzilli, Stefania

AU - Di Lisio, Chiara

AU - D'Amore, Simona

AU - Bertrand-Michel, Justine

AU - Montagner, Alexandra

AU - Pineau, Thierry

AU - Loiseau, Nicolas

AU - Lobaccaro, Jean Marc

AU - Martin, Pascal G P

AU - Guillou, Hervé

PY - 2013/3

Y1 - 2013/3

N2 - The Liver X Receptors (LXRs) α and β and the Peroxisome Proliferator-Activated Receptor α (PPARα) are transcription factors that belong to class II nuclear receptors. They drive the expression of genes involved in hepatic lipid homeostasis and therefore are important targets for the prevention and treatment of nonalcoholic fatty liver disease (NAFLD). LXRs and PPARα are regulated by endogenous ligands, oxysterols and fatty acid derived molecules, respectively. In the liver, pharmacological activation of LXRs leads to the over-expression of genes involved in de novo lipogenesis, while PPARα is critical for fatty acid catabolism in nutrient deprivation. Even if these two nuclear receptors seemed to play opposite parts, recent studies have highlighted that PPARα also influence the expression of genes involved in fatty acids synthesis. In this study, we used pharmacological approaches and genetically engineered mice to investigate the cross-talk between LXRs and PPARα in the regulation of genes responsible for lipogenesis. We first investigated the effect of T0901317 and fenofibrate, two synthetic agonists of LXRs and PPARα, respectively. As expected, T0901317 and fenofibrate induce expression of genes involved LXR-dependent and PPARα-dependent lipogenic responses. Considering such overlapping effect, we then tested whether LXR agonist may influence PPARα driven response and vice versa. We show that the lack of PPARα does not influence the effects of T0901317 on lipogenic genes expression. However, PPARα deficiency prevents the up-regulation of genes involved in ω-hydroxylation that are induced by the LXR agonist. In addition, over-expression of lipogenic genes in response to fenofibrate is decreased in LXR knockout mice as well as the expression of PPARα target genes involved in fatty acid oxidation. Altogether, our work provides in vivo evidence for a central interconnection between nuclear receptors that drive hepatic lipid metabolism in response to oxysterol and fatty acids.

AB - The Liver X Receptors (LXRs) α and β and the Peroxisome Proliferator-Activated Receptor α (PPARα) are transcription factors that belong to class II nuclear receptors. They drive the expression of genes involved in hepatic lipid homeostasis and therefore are important targets for the prevention and treatment of nonalcoholic fatty liver disease (NAFLD). LXRs and PPARα are regulated by endogenous ligands, oxysterols and fatty acid derived molecules, respectively. In the liver, pharmacological activation of LXRs leads to the over-expression of genes involved in de novo lipogenesis, while PPARα is critical for fatty acid catabolism in nutrient deprivation. Even if these two nuclear receptors seemed to play opposite parts, recent studies have highlighted that PPARα also influence the expression of genes involved in fatty acids synthesis. In this study, we used pharmacological approaches and genetically engineered mice to investigate the cross-talk between LXRs and PPARα in the regulation of genes responsible for lipogenesis. We first investigated the effect of T0901317 and fenofibrate, two synthetic agonists of LXRs and PPARα, respectively. As expected, T0901317 and fenofibrate induce expression of genes involved LXR-dependent and PPARα-dependent lipogenic responses. Considering such overlapping effect, we then tested whether LXR agonist may influence PPARα driven response and vice versa. We show that the lack of PPARα does not influence the effects of T0901317 on lipogenic genes expression. However, PPARα deficiency prevents the up-regulation of genes involved in ω-hydroxylation that are induced by the LXR agonist. In addition, over-expression of lipogenic genes in response to fenofibrate is decreased in LXR knockout mice as well as the expression of PPARα target genes involved in fatty acid oxidation. Altogether, our work provides in vivo evidence for a central interconnection between nuclear receptors that drive hepatic lipid metabolism in response to oxysterol and fatty acids.

KW - Lipogenesis

KW - LXR

KW - Oxysterol

KW - PPARα

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=84874112449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874112449&partnerID=8YFLogxK

U2 - 10.1016/j.biochi.2012.09.028

DO - 10.1016/j.biochi.2012.09.028

M3 - Article

VL - 95

SP - 556

EP - 567

JO - Biochimie

JF - Biochimie

SN - 0300-9084

IS - 3

ER -